Contributing factors of contralateral breast cancer in patients with BRCA mutation (ON-BRCA II study, KoREa-BSG 11)
Open Access
- 9 April 2026
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research
- Vol. 28 (1)
Abstract
The cumulative risk of contralateral breast cancer (CBC) in BRCA1/2 carriers is remarkably higher than in non-carriers. This study aimed to investigate theKeywords
This publication has 23 references indexed in Scilit:
- Operating on Anxiety: Negative Affect toward Breast Cancer and Choosing Contralateral Prophylactic MastectomyMedical Decision Making, 2022
- Lifestyle Characteristics in Women Carriers of BRCA Mutations: Results From an Italian Trial CohortClinical Breast Cancer, 2021
- Exploratory Visual Inspection of Category Associations and Correlation Estimation in Multidimensional SubspacesJournal of Classification, 2018
- Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation CarriersJAMA, 2017
- The structure of obsessive compulsive symptoms and beliefs: A correspondence and biplot analysisJournal of Anxiety Disorders, 2016
- Cumulative risk of second primary contralateral breast cancer in BRCA1/BRCA2 mutation carriers with a first breast cancer: A systematic review and meta-analysisThe Breast, 2014
- Survival Outcomes After Contralateral Prophylactic Mastectomy: A Decision AnalysisJNCI: Journal of the National Cancer Institute, 2014
- Contralateral risk-reducing mastectomy in sporadic breast cancerThe Lancet Oncology, 2013
- Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and MortalityJAMA, 2010
- Support needs and acceptability of psychological and peer consultation: attitudes of 108 women who had undergone or were considering prophylactic mastectomyPsycho-Oncology, 2008